Trials / Completed
CompletedNCT04547634
Telerehabilitation in Oncology Patients
Effect of a Telerehabilitation-exercise Intervention in Oncology Patients in the Covid-19 Pandemic
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University of Malaga · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim is to analyze the feasibility and effect of an online Therapeutic Exercise and Education programme (TEEP) in cancer patient and survivors
Detailed description
Current literature shows that Therapeutic Exercise has multiple benefits in oncology patients, such as improvements in function and quality of life, and ameliorates symptoms such as cancer-related fatigue. Furthermore, given the risk of obesity, both exercise and diet play a key role in recovery from cancer. In fact, current guidelines support the use of exercise with therapeutic purposes as a complement to cancer treatment. As a consequence of the COVID-19 pandemic, oncology patients present more difficulties to attend programs, as the vast majority are immunosuppressed, and they are considered risk population. Therefore, new online (TEEP) must be developed to facilitate the benefits of these programs in the post-COVID Era. This study analyses the feasibility (in terms of suitability and verification of exercise prescription, absence and attendance type, and total days of attendance) and the effect (in weight, physical function, and symptoms) in cancer patients and survivors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Therapeutic Exercise and Education | The intervention will consist of 30 minutes of strength exercises followed by 20 minutes of endurance with aerobic training, individualized based on the evaluations of muscular strength and endurance. Sessions lasted 1 hour, carried out twice a week, for 12 weeks. This intervention will be complemented by nutritional education. |
Timeline
- Start date
- 2023-10-01
- Primary completion
- 2024-11-01
- Completion
- 2024-12-01
- First posted
- 2020-09-14
- Last updated
- 2026-04-08
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04547634. Inclusion in this directory is not an endorsement.